i-Target

International training program – Elite Network of Bavaria.

Focusing on targeted cell-based therapies, targeted antibody therapy and immunomodulatory therapy

[Cancer Cell @Cancer_Cell]

Challenges and Opportunities for Pancreatic Cancer Immunotherapy https://t.co/G1qP5P7fsF

[i-Target @iTarget_ENB]

Last seminar of 2020!

Great results colloquium from Magdalena Zaucha on the influence of genetic factors on immune response to Yellow Fever vaccination! Thank you, @magdalenazaucha!

[medtoday Germany @medtodaygermany]

#CARTcell Therapie News vom #ASH20. Beim #ASHToday zusammengefasst von Prof. Peter Bader von der Uniklinik Frankfurt, Prof. Andreas Mackensen von der Uniklinik Erlangen, Prof. @MSubklewe vom @LMU_Uniklinikum und Prof. Simone Thomas von der @presse_ukr
👉 https://t.co/8qmKv4RS5z!

[i-Target @iTarget_ENB]

On the second day it was a pleasure to learn more about the Roll of RNA in Cancer. A big "thank you" to our speakers Prof. Dr. Sven Diederichs, Dr. Gunhild Sommer, Prof. Dr. Gunter Meister, and Dr. Markus Krentz for their very nice and informative talks!

[i-Target @iTarget_ENB]

Last week the students enjoyed two days at the the i-Target fall workshop (virtually of course).
(Thread)

[i-Target @iTarget_ENB]

On the first day we had a lot of fun with our trainer Dr. Daniel Mertens at the very encouraging "Scientists Need More! Grant Writing and Getting Funded" Soft Skill workshop!

[i-Target @iTarget_ENB]

Weekly seminar

Very insightful talk given by our guest speaker, Dr. Carsten Marr from the Institute of Computational Biology, @HelmholtzMunich on artificial intelligence in computational hematopathology.
Thank you, @MarrCarsten!

[i-Target @iTarget_ENB]

Weekly seminar

Great results colloquium by @AnneMarieSenz on the impact of IDO1 depletion in adoptive T cell therapy!

Journal club:

https://t.co/W5poLCHtu4

[hopfnerlab @hopfnerlab]

Congrats to Saskia on her successful PhD defense! One of the pioneers of our antibody subgroup and a great person and scientist!

[i-Target @iTarget_ENB]

Weekly seminar

Results colloquium from Malte Ohlmeyer on modulation of T cell function by costimulatory and coinhibitory molecules during continuous application of T cell recruiting constructs for treatment of B cell malignancies.

Journal club:

https://t.co/s0JnWZuEB8

[i-Target @iTarget_ENB]

Weekly seminar

Great results colloquium from @antoniosnews on generation of protective anti-viral immunity by the effective immunopriming of yellow fever vaccine virus!

Journal club:

https://t.co/HnrT5z5jJ4

[i-Target @iTarget_ENB]

Thank you to the organizers and speakers for making the #itoc7 an amazing virtual conference!

@ITOCconference

[13th Immunotherapy of Cancer Conference @ITOCconference]

Thank you to all participants of #itoc7. We hope you had a great virtual conference. See you next year at #itoc8!

[LMU Clinical Pharmacology @KlinPharm]

Check out the poster by our PhD candidate @AnneMarieSenz on how IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models @ITOCconference @LMU_Uniklinikum @LMU_Muenchen @iTarget_ENB #Immunotherapy #CARTcells #IDO1 #PancreaticCancer

[13th Immunotherapy of Cancer Conference @ITOCconference]

Welcome to the 7th Immunotherapy of Cancer Virtual Conference! Join us for our welcome address https://t.co/aKa8tvwuCE

[LMU Clinical Pharmacology @KlinPharm]

Excited to hear about Synthetic agonistic receptor-activating BiTEs - a modular platform for the efficient targeting of acute myeloid leukemia from M.Res. Mohamed-Reda Benmebarek @BenmebarekMr on Saturday at @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #leukemia

[LMU Clinical Pharmacology @KlinPharm]

Check out the poster from our medical student Carlotta Rambuscheck: Exploring tumor-intrinsic factors regulating the recruitment of myeloid-derived suppressor cells (MDSC) in pancreatic ductal adenocarcinoma.
Coming soon at @ITOCconference @LMU_Muenchen @LMU_Uniklinikum #ITOC7

[LMU Clinical Pharmacology @KlinPharm]

Excited to hear Dr. Daniel Böhmer talk on how Gemcitabine induces pro-apoptotic BH3 only proteins and sensitizes pancreatic ductal adenocarcinoma cells for RLH-triggered immunogenic cell death @ITOCconference @LMU_Uniklinikum #PancreaticCancer #Immunotherapy #ITOC7 #CancerTherapy

[LMU Clinical Pharmacology @KlinPharm]

Check out the poster from Dr. Bruno L. Cadilha @bcadilha : C-C chemokine receptor 8 tumor-directed recruitment enables CAR T cells to reject solid tumors. Coming soon @ITOCconference @LMU_Uniklinikum @LMU_Muenchen #Immunotherapy #CARTcells #ITOC7 #CancerTherapy

[LMU Clinical Pharmacology @KlinPharm]

Looking forward to Prof. Dr. Sebastian Kobolds talk on why adoptive T cells therapies fail for solid tumors. @ITOCconference on Saturday 3rd of October #Immunotherapy #cancerresearch #ITOC7

https://t.co/ur8JkJoRjJ

[13th Immunotherapy of Cancer Conference @ITOCconference]

One Week To Go!
Join us for the ITOC7 Virtual Conference on Friday, October 2 and Saturday, October 3, 2020!
https://t.co/QeeYB84ERF